Effects of a specific thromboxane A2 synthetase inhibitor on lymphocyte and neutrophil functions in adult intractable asthmatics

A. Kanehiro, K. Takahashi, R. Soda, M. Takata, K. Takeda, H. Sugano, K. Yamagata, Y. Katagi, I. Kimura

Research output: Contribution to journalArticle

Abstract

To clarify whether thromboxane A2 (TXA2) is involved in type III and IV allergy, or so called 'cell-mediated allergy', we studied the effect of a specific TXA2 synthetase inhibitor, sodium ozagrel (OKY-046) on peripheral blood mononuclear cells and neutrophils in adult intractable asthmatics. The results revealed, firstly, that lymphocyte blastogenesis and interleukin-2 (IL-2) production from peripheral blood mononuclear cells stimulated by PHA and Candida antigen in intractable asthmatics was significantly suppressed dose-dependently by OKY-046. Secondly, there was a tendency that neutrophil chemotactic factor (NCF) and eosinophil chemotactic factor (ECF) from peripheral blood mononuclear cells stimulated by Candida antigen in intractable asthmatics were suppressed by OKY-046. Thirdly, leukotriene (LTC4) and superoxide (O2-) production from peripheral blood neutrophils in intractable asthmatics was significantly suppressed dose-dependently by OKY-046. That is, OKY-046 has a suppressive effect on type IV allergy caused by lymphocyte activation and on mediator release from neutrophils. These results suggest that TXA2 plays an important role in the development of bronchial asthma and OKY-046 might be a useful drug in the treatment of intractable asthmatics.

Original languageEnglish
Pages (from-to)584-594
Number of pages11
JournalArerugī = [Allergy]
Volume41
Issue number5
Publication statusPublished - 1992

Fingerprint

Thromboxane-A Synthase
Neutrophils
Lymphocytes
Blood Cells
Hypersensitivity
Thromboxane A2
Lymphocyte Activation
Candida
Eosinophil Chemotactic Factors
Antigens
Leukotriene C4
Leukotrienes
ozagrel
Interleukin-8
Superoxides
Interleukin-2
Asthma

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Kanehiro, A., Takahashi, K., Soda, R., Takata, M., Takeda, K., Sugano, H., ... Kimura, I. (1992). Effects of a specific thromboxane A2 synthetase inhibitor on lymphocyte and neutrophil functions in adult intractable asthmatics. Arerugī = [Allergy], 41(5), 584-594.

Effects of a specific thromboxane A2 synthetase inhibitor on lymphocyte and neutrophil functions in adult intractable asthmatics. / Kanehiro, A.; Takahashi, K.; Soda, R.; Takata, M.; Takeda, K.; Sugano, H.; Yamagata, K.; Katagi, Y.; Kimura, I.

In: Arerugī = [Allergy], Vol. 41, No. 5, 1992, p. 584-594.

Research output: Contribution to journalArticle

Kanehiro, A, Takahashi, K, Soda, R, Takata, M, Takeda, K, Sugano, H, Yamagata, K, Katagi, Y & Kimura, I 1992, 'Effects of a specific thromboxane A2 synthetase inhibitor on lymphocyte and neutrophil functions in adult intractable asthmatics', Arerugī = [Allergy], vol. 41, no. 5, pp. 584-594.
Kanehiro, A. ; Takahashi, K. ; Soda, R. ; Takata, M. ; Takeda, K. ; Sugano, H. ; Yamagata, K. ; Katagi, Y. ; Kimura, I. / Effects of a specific thromboxane A2 synthetase inhibitor on lymphocyte and neutrophil functions in adult intractable asthmatics. In: Arerugī = [Allergy]. 1992 ; Vol. 41, No. 5. pp. 584-594.
@article{0e22d4f1fc9943ce8fd3743beb267baa,
title = "Effects of a specific thromboxane A2 synthetase inhibitor on lymphocyte and neutrophil functions in adult intractable asthmatics",
abstract = "To clarify whether thromboxane A2 (TXA2) is involved in type III and IV allergy, or so called 'cell-mediated allergy', we studied the effect of a specific TXA2 synthetase inhibitor, sodium ozagrel (OKY-046) on peripheral blood mononuclear cells and neutrophils in adult intractable asthmatics. The results revealed, firstly, that lymphocyte blastogenesis and interleukin-2 (IL-2) production from peripheral blood mononuclear cells stimulated by PHA and Candida antigen in intractable asthmatics was significantly suppressed dose-dependently by OKY-046. Secondly, there was a tendency that neutrophil chemotactic factor (NCF) and eosinophil chemotactic factor (ECF) from peripheral blood mononuclear cells stimulated by Candida antigen in intractable asthmatics were suppressed by OKY-046. Thirdly, leukotriene (LTC4) and superoxide (O2-) production from peripheral blood neutrophils in intractable asthmatics was significantly suppressed dose-dependently by OKY-046. That is, OKY-046 has a suppressive effect on type IV allergy caused by lymphocyte activation and on mediator release from neutrophils. These results suggest that TXA2 plays an important role in the development of bronchial asthma and OKY-046 might be a useful drug in the treatment of intractable asthmatics.",
author = "A. Kanehiro and K. Takahashi and R. Soda and M. Takata and K. Takeda and H. Sugano and K. Yamagata and Y. Katagi and I. Kimura",
year = "1992",
language = "English",
volume = "41",
pages = "584--594",
journal = "Japanese Journal of Allergology",
issn = "0021-4884",
publisher = "Japanese Society of Allergology",
number = "5",

}

TY - JOUR

T1 - Effects of a specific thromboxane A2 synthetase inhibitor on lymphocyte and neutrophil functions in adult intractable asthmatics

AU - Kanehiro, A.

AU - Takahashi, K.

AU - Soda, R.

AU - Takata, M.

AU - Takeda, K.

AU - Sugano, H.

AU - Yamagata, K.

AU - Katagi, Y.

AU - Kimura, I.

PY - 1992

Y1 - 1992

N2 - To clarify whether thromboxane A2 (TXA2) is involved in type III and IV allergy, or so called 'cell-mediated allergy', we studied the effect of a specific TXA2 synthetase inhibitor, sodium ozagrel (OKY-046) on peripheral blood mononuclear cells and neutrophils in adult intractable asthmatics. The results revealed, firstly, that lymphocyte blastogenesis and interleukin-2 (IL-2) production from peripheral blood mononuclear cells stimulated by PHA and Candida antigen in intractable asthmatics was significantly suppressed dose-dependently by OKY-046. Secondly, there was a tendency that neutrophil chemotactic factor (NCF) and eosinophil chemotactic factor (ECF) from peripheral blood mononuclear cells stimulated by Candida antigen in intractable asthmatics were suppressed by OKY-046. Thirdly, leukotriene (LTC4) and superoxide (O2-) production from peripheral blood neutrophils in intractable asthmatics was significantly suppressed dose-dependently by OKY-046. That is, OKY-046 has a suppressive effect on type IV allergy caused by lymphocyte activation and on mediator release from neutrophils. These results suggest that TXA2 plays an important role in the development of bronchial asthma and OKY-046 might be a useful drug in the treatment of intractable asthmatics.

AB - To clarify whether thromboxane A2 (TXA2) is involved in type III and IV allergy, or so called 'cell-mediated allergy', we studied the effect of a specific TXA2 synthetase inhibitor, sodium ozagrel (OKY-046) on peripheral blood mononuclear cells and neutrophils in adult intractable asthmatics. The results revealed, firstly, that lymphocyte blastogenesis and interleukin-2 (IL-2) production from peripheral blood mononuclear cells stimulated by PHA and Candida antigen in intractable asthmatics was significantly suppressed dose-dependently by OKY-046. Secondly, there was a tendency that neutrophil chemotactic factor (NCF) and eosinophil chemotactic factor (ECF) from peripheral blood mononuclear cells stimulated by Candida antigen in intractable asthmatics were suppressed by OKY-046. Thirdly, leukotriene (LTC4) and superoxide (O2-) production from peripheral blood neutrophils in intractable asthmatics was significantly suppressed dose-dependently by OKY-046. That is, OKY-046 has a suppressive effect on type IV allergy caused by lymphocyte activation and on mediator release from neutrophils. These results suggest that TXA2 plays an important role in the development of bronchial asthma and OKY-046 might be a useful drug in the treatment of intractable asthmatics.

UR - http://www.scopus.com/inward/record.url?scp=0026755927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026755927&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 584

EP - 594

JO - Japanese Journal of Allergology

JF - Japanese Journal of Allergology

SN - 0021-4884

IS - 5

ER -